Navigation Links
Rapidly in Medical Technology

NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting

... recognized for pursuit of cost-effective and rapidly deployed vaccine solution for avian ... manufacturing process makes it possible to rapidly produce an influenza vaccine that contains ... tolerated and immunogenic and can be produced rapidly to supply vaccine against an emerging pandemic ...

St. Jude Study Finds Treatment With New Drug Might Make Tumor Cells More Sensitive to Therapy

... in the laboratory that a molecule called CP466722 rapidly blocks the ATM protein's ability to orchestrate ... its effect in small quantities, and its effects rapidly ended after it was removed from cells, suggesting ... of the double-stranded break. "Our ability to rapidly and reversibly regulate ATM activity ...

BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union

... BRIDION allows anesthesiologists to rapidly reverse both moderate and deep ... and pulmonary side effects. "The ability to rapidly reverse both moderate and deep levels of ... in two decades. It was specifically designed to rapidly reverse both moderate and deep muscle relaxation ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... 39% in inferior MIs) in patients who were cooled rapidly to <35 degrees Celsius prior to reperfusion with ... temperature modulation, which is designed to rapidly and controllably cool the body in order to reduce ... sensor, and a programmable console capable of rapidly and controllably inducing, maintaining and ...

PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.

... FDA's input into our final study protocol, and rapidly moving through the next phase of our clinical ... during imaging procedures allows the body to rapidly eliminate toxins in contrast media, ... these procedures. This should allow the body to rapidly eliminate contrast, reducing its toxic effects. ...

Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions

... Clotting Factor IXa; Matched Antidote rapidly Reverses Anticoagulant Effect ORLANDO, Fla., ... to blood clotting, and RB006's activity was rapidly and safely reversed by RB007 in the Phase I ... of the REG1 system, the ability to rapidly anticoagulate and then reverse this effect," ...

GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial

... the GeoVax vaccines elicit T cell responses that rapidly mobilize and then contract into a state called "central memory" from which they rapidly expand to fight the appearance of HIV. Merck's ... cells and can compromise the ability to rapidly expand in the fight against an infection. "The ...

Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System

... ThermoSuit System uses innovative technology to rapidly cool a patient's core temperature. It consists of ... that conveniently provides a thin layer of rapidly flowing liquid coolant in direct contact with the ... the ThermoSuit System outstanding capabilities to rapidly and non-invasively change patient temperature. ...

Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease

... the lives of patients with chronic disease and continues our commitment to rapidly deploy diagnostics and develop new treatments for devastating diseases ... sooner and more effectively before symptoms intensify and the disease rapidly escalates." The only non-profit independent institution in the world ...

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

... utilize the CMC proprietary CHEF1(R) expression technology, a system that rapidly generates production cell lines and provides the flexibility to quickly ... Acute lung injury (ALI) is a severe inflammatory disease which can rapidly progress to acute respiratory distress syndrome, multi-organ dysfunction ...

Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate

... approach Novavax's manufacturing process makes it possible to rapidly produce a vaccine that contains strains that are an exact genetic match to ... half the time required to manufacture egg-based vaccines. The ability to rapidly respond to the identification of annual seasonal strains may be important ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... (imatinib mesylate) tablets* is the standard treatment for Ph+ CML and rapidly transformed the treatment of CML when it was introduced in 2001. An ... < 0.1%. The percentage of patients achieving this level of response rapidly increased after one month of treatment. Adverse reactions were manageable ...

Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer

... in Marseille adds: "I was very pleased to collaborate with Ipsogen in rapidly and efficiently moving from our research findings to a market-ready ... Dx(TM) is a comprehensive "plug & play" solution, making research rapidly available to patients". About MapQuant Dx(TM) HER2 ...

Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy

... On-demand Xpert MRSA results enable Australian healthcare professionals to rapidly identify MRSA colonized patients entering the hospital population, thereby ... strategy also allocates funds to help hospitals implement systems to rapidly diagnose MRSA and other significant organisms. Other Australian states ...

Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections

... use," said Dr. Susan Froshauer, President and CEO of Rib-X. "We intend to rapidly move forward with the development of our IV dosage form to meet the need ... medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance ...

Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System

... protein essential to blood clotting and that RB006's activity was reversed rapidly and safely by RB007. The article, titled, "A Phase 1b Randomized Study ... in Circulation provide further evidence of the REG1 system's ability to rapidly and predictably anticoagulate and then to reverse this effect as needed in ...

Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer

... In such preoperative chemotherapy settings, treatment efficacy can be rapidly & precisely assessed by examining the resected tumor in a ... cancer>> says Vincent Fert, CEO of Ipsogen. "We are fully committed to rapidly translate these clinical findings into regulatory-approved and reimbursed ...

NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting

... 45 and 100 minutes for naloxone.(1) At all dose levels, NKTR-118 was rapidly absorbed after oral administration, as evidenced by a steep increase of ... NKTR-118 at single doses up to 1,000 mg was well-tolerated. The drug was rapidly absorbed with dose-proportional pharmacokinetics over the 8-1,000 mg dose ...

Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia

... candidate is an exciting milestone for Catalyst. Created to more rapidly and effectively stop bleeding, CB 813 holds great promise as a new agent ... to target proteins underlying disease. Catalyst's discovery platform rapidly creates and optimizes tailor-made protease drug candidates, called ...

Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology

... for the cardiologist. "The VentriPoint Diagnostic System's ability to rapidly and easily provide right ventricle measurement in multiple disease areas, ... Diagnostic System, improves existing medical imaging systems to rapidly and cost effectively obtain measurements that are critical but currently ...

GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results

... of antigen from the GeoVax vaccines elicit T cell responses that rapidly mobilize and then contract into a state called "central memory" from which they rapidly expand to fight the appearance of HIV. -- In November, GeoVax ...

FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008

... a smart, "soft drug" inactivation process. Specifically, ARI-2243 binds rapidly and tightly to DPP-4 and once bound, the complex dissociates very slowly, ... (DPP) - 4 is a naturally occurring, proteolytic enzyme that rapidly degrades the incretin hormones, gastric inhibitory polypeptide (GIP) and ...

On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments

... the phase I feasibility portion of the award and are looking forward to rapidly executing the rest of the project." About Compendia Bioscience, Inc. ... About Oncomine(TM) Oncomine(TM) combines a rapidly growing compendium of 24,000+ cancer transcriptome profiles with a ...

PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)

... maintaining high urine output during imaging procedures allows the body to rapidly eliminate toxins in contrast media, reducing their harmful effects. The ... before, during and after these procedures. This should allow the body to rapidly eliminate contrast, reducing its toxic effects. The RenalGuard System, ...

Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.

... efficacy in the treatment of diabetes, a disease of large and rapidly increasing prevalence." "Molecules capable of mimicking the biological ... products across numerous therapeutic areas. Ambrx has successfully and rapidly applied its innovative technology platform to advance into the clinic with ...

Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke

... setting as it is a clot-dissolver that holds the potential to directly and rapidly dissolve blood clots while keeping its activity localized to the site of ... a recombinant direct acting fibrinolytic (rDAF) that has the potential to rapidly dissolve blood clots through a unique mechanism of action -- it directly ...

Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus

... and community acquired MRSA and SA infections have been shown to be rapidly increasing. We believe that the unique ability of the GeneXpert System to ... in approximately 50 minutes, thereby enabling healthcare professionals to rapidly determine the presence or absence of MRSA and SA with a single test. In ...

GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update

... of antigen from the GeoVax vaccines elicit T cell responses that rapidly mobilize and then contract into a state called "central memory" from which they rapidly expand to fight the appearance of HIV. -- In November, GeoVax ...

JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers

... in accelerating the development of therapeutics by enabling researchers to rapidly assess the clinical outcomes of promising drug candidates. "Biomarkers ... to the progress of diabetes research," Dr. Burn said. "This project can rapidly advance the pace of scientific discovery and therapeutic developments for ...

EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407

... Screening Apoptosis Program (ASAP), a proprietary technology used to rapidly test and generate product candidates for cancer. EPC2407 has shown ... screening technology allows EpiCept's researchers to discover and rapidly test the effect of small molecules on pathways and molecular targets ...

Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch

... quarter of 2007. Following the completion of this study, Cerimon plans to rapidly initiate late-stage efficacy and safety studies of its diclofenac sodium ... study of a topical patch formulation of diclofenac sodium. This study will rapidly be followed by late-stage efficacy and safety studies in patients with ...

AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study

... leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction ... of its two first-generation blood-based human diagnostic tests designed to rapidly help diagnose or rule out appendicitis in patients complaining of ...

Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion

... active thrombolytic which has the potential to dissolve clots quickly and rapidly restore catheter function, however, the dose and concentration we used did ... a recombinant direct acting fibrinolytic (rDAF) that has the potential to rapidly dissolve blood clots through a unique mechanism of action -- it directly ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... brachytherapy. This latest advance in brachytherapy allows physicians to deliver precise radiation treatment to a patient's cancerous tumor and is rapidly becoming the treatment of choice for certain types of cancer. With HDR brachytherapy, radiation is delivered directly to the cancer target ...

DNA Helps Reunite Children With Their Families

... had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of ...

New Powder Speeds Healing of Difficult Foot Wounds

... Medical Association's (APMA) 97th Annual Scientific Meeting in Toronto, July 30 - August 2, 2009, and will highlight the powder's unique ability to rapidly heal foot wounds and advance the treatment patients currently receive. (Logo: http://www.newscom.com/cgi-bin/prnh/20090730/DC54472LOGO ) ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... changes were permanent and heritable. Together, these results demonstrate the ability to deliver engineered ZFNs into early-stage embryos and rapidly generate heritable, knockout mutations in a whole organism. Rats are physiologically more similar to humans than are mice for many traits ...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

... leftovers safely. Hot foods can go straight into the refrigerator or freezer. They shouldn't be left out to cool on the counter. Hot foods can be rapidly cooled by dipping the bowl or container in ice or a cold-water bath. Leftovers from a large pot will cool more quickly when divided into smaller, ...

Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

... Proximal Anastomosis System Advantage The innovative design of the PAS-Port system allows a surgeon to load the bypass graft into the system and rapidly complete the anastomosis, typically in approximately two minutes, with little or no injury to the bypass graft vessel or the aorta. As of March 31, ...

UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201

... promising safety and efficacy results in patients with solid tumors. "We are extremely pleased to be launching the Phase 3 clinical trial so rapidly after the close of the Phase 2 trial," said Barry Sherman, M.D., head of clinical development at South San Francisco-based BiPar Sciences, which is ...
Other Contents
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been ... banking account but can,t remember your password, site key or ... Who was your first grade teacher? Today, ... the app that will finally put an end ... – 1U TM . 1U leverages a user,s ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
(Date:12/17/2014)... Myo Nwe is the co-author of a new weight loss ... of the Ace Medical Weight Loss Center in Rock Hill, ... at the industry of weight loss, and how several fad ... in television shows, however, she says the topic of obesity ... for basic laughs, which she believes impacts whether Americans view ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 This ... private practices that have made outstanding and innovative ... support and progression of private practice physical therapy ... Physical Therapy Association. , On behalf of Performance ... owner and CEO of Performance accepted the award ...
(Date:12/17/2014)... A group of 127 scientists sent an “open letter” ... a recent statement by the center that was highly critical ... efficacy of all brain exercises. , Signatories to the open ... center’s statement critical of brain exercise companies that overstate their ... case, in a document it had entitled “A Consensus on ...
(Date:12/17/2014)... No matter how far modern medicine ... the head louse parasite—a common childhood malady and a ... between six and twelve million individuals will suffer an ... treatment company comes to the rescue, providing an all-natural ... its track record of customer service, and effectiveness in ...
(Date:12/17/2014)... 2014 Project Veritas is releasing a ... of MIT economist and Obamacare architect Jonathan Gruber to ... conducted the interview, which is being distributed on YouTube. ... intentional mislabeling in the Affordable Care Act in order ... two-hundred-and-fifty billion dollar per year tax grab. , “President ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
Other TagsOther Tags